In today’s environment when adults become sick, or are seeking information about a diet, they are turning more and more to the internet as their first line resource of information. The internet is slowly changing the face of medicine and has become one of the most valuable social media tools in the field of clinical research, specifically to increase patient recruitment. Social media is a form of marketing that can potentially cost little for sponsors and CROs, and can reach a broad audience who may have a great interest in the trial. Join us to hear an overview of today’s social media landscape and how you can make it work for your site! It is also critical to understand the ethical and regulatory implications of the use of social media in the area of drug development. There are very specific IRB and FDA regulations regarding the direct marketing and promotion of clinical trials since it is considered to be the start of the informed consent and subject recruitment process. Our expert speaker will share regulatory considerations and enlighten us with the evolving process of social media that can help to alleviate many individual, institutional, and regulatory obstacles as we move forward in the changing backdrop of clinical research.
Nicole Carswell, Director, Patient Recruitment Strategy, Site and Patient Networks (SPN), Quintiles